Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2015PLoS MedicineOpen Access

Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPamela MarisUniversity of LiègeABArnaud BlommeUniversity of LiègeAPAna Perez Palacios

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maris et al. (2015) studied this question.

synapsesocial.com/papers/6a0f24fbb7d829a1276c94e7https://doi.org/10.1371/journal.pmed.1001871
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment2006 · 460 citations
  2. 2The Emerging Role of the Molecular Diagnostics Laboratory in Breast Cancer Personalized Medicine2013 · 48 citations
  3. 3Regulation, Regulatory Activities, and Function of Biglycan2004 · 45 citations
  4. 4Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs2008 · 164 citations